Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- AI adoption surges, but providers worry about deskilling (Healthcare Dive)
- The gastroenterologist pay gap (Becker’s GI & Endoscopy)
- 8 No Surprises Act shake-ups physicians need to know (Becker’s Healthcare)
- ChristianaCare researchers identify genetic drivers of aggressive CRC (Becker’s GI & Endoscopy)
- A Collaborative Approach for Advanced IBD Therapy Prior Authorization Denials (GI & Endoscopy News)
- Personalized Nutrition: The Future of Gastroenterology (Grand View Research)
- Mindray Leads the Evolution of Gastroenterology Imaging with the Newly Expanded Hepatus-Series Ultrasound Systems (PR Newswire)
- How NYU Langone is helping modernize a decades-old GI surgery tool (Becker’s GI & Endoscopy)
